(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1316551 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC27A4 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions ISO RGD:1316552 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of SLC27A4 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1316552 6480464 1, 2-Dimethylhydrazine results in increased expression of SLC27A4 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:1316551 6480464 Estradiol affects the expression of SLC27A4 mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1316551 6480464 Estradiol results in increased expression of SLC27A4 mRNA CTD PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1316552 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1316551 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316552 6480464 Tetrachlorodibenzodioxin affects the expression of SLC27A4 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC27A4 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316552 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316551 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC27A4 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316552 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC27A4 mRNA CTD PMID:22539624 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC27A4 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1316551 6480464 Lactic Acid results in decreased expression of SLC27A4 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl affects expression ISO RGD:1316551 6480464 3 more ... CTD PMID:21703328 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1316552 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of SLC27A4 mRNA CTD PMID:20188158 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of SLC27A4 mRNA CTD PMID:21346803 8-Br-cAMP decreases expression ISO RGD:1316551 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC27A4 mRNA CTD PMID:22079614 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SLC27A4 mRNA CTD PMID:33354967 all-trans-retinoic acid decreases expression ISO RGD:1316551 6480464 Tretinoin results in decreased expression of SLC27A4 mRNA CTD PMID:33167477 benzo[a]pyrene decreases expression ISO RGD:1316552 6480464 Benzo(a)pyrene results in decreased expression of SLC27A4 mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1316552 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC27A4 mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A increases expression ISO RGD:1316551 6480464 bisphenol A results in increased expression of SLC27A4 protein CTD PMID:32981897 bisphenol A multiple interactions ISO RGD:1316552 6480464 [Dietary Sucrose co-treated with Dietary Fats co-treated with bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:30722647 bisphenol A affects expression ISO RGD:1316551 6480464 bisphenol A affects the expression of SLC27A4 mRNA CTD PMID:30903817 bisphenol A affects methylation ISO RGD:1316552 6480464 bisphenol A affects the methylation of SLC27A4 promoter CTD PMID:27334623 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SLC27A4 mRNA CTD PMID:19167457 chromium(6+) affects expression ISO RGD:1316552 6480464 chromium hexavalent ion affects the expression of SLC27A4 mRNA CTD PMID:28472532 cisplatin decreases expression ISO RGD:1316551 6480464 Cisplatin results in decreased expression of SLC27A4 mRNA CTD PMID:27594783 clofibrate multiple interactions ISO RGD:1316552 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC27A4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC27A4 mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:1316552 6480464 Clofibrate results in increased expression of SLC27A4 mRNA CTD PMID:17585979 cobalt dichloride decreases expression ISO RGD:1316551 6480464 cobaltous chloride results in decreased expression of SLC27A4 mRNA CTD PMID:19320972 dextran sulfate multiple interactions ISO RGD:1316552 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC27A4 mRNA CTD PMID:29950665 dicrotophos increases expression ISO RGD:1316551 6480464 dicrotophos results in increased expression of SLC27A4 mRNA CTD PMID:28302478 dioxygen decreases expression ISO RGD:1316551 6480464 Oxygen deficiency results in decreased expression of SLC27A4 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:1316552 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC27A4 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1316551 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A4 mRNA CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC27A4 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1316552 6480464 epoxiconazole results in decreased expression of SLC27A4 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:1316552 6480464 Ethanol results in increased expression of SLC27A4 mRNA CTD PMID:19167417 ethanol affects splicing ISO RGD:1316552 6480464 Ethanol affects the splicing of SLC27A4 mRNA CTD PMID:30319688 fenofibrate multiple interactions ISO RGD:1316552 6480464 PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of SLC27A4 mRNA], PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of SLC27A4 protein] CTD PMID:24752549 fenofibrate increases expression ISO RGD:1316551 6480464 Fenofibrate results in increased expression of SLC27A4 mRNA, Fenofibrate results in increased expression of SLC27A4 protein CTD PMID:24752549 fenofibrate increases expression ISO RGD:1316552 6480464 Fenofibrate results in increased expression of SLC27A4 mRNA, Fenofibrate results in increased expression of SLC27A4 protein CTD PMID:24752549 fenofibrate multiple interactions ISO RGD:1316551 6480464 PPARA protein promotes the reaction [Fenofibrate results in increased expression of SLC27A4 protein] CTD PMID:24752549 finasteride decreases expression EXP 6480464 Finasteride results in decreased expression of SLC27A4 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SLC27A4 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1316552 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of SLC27A4 mRNA] CTD PMID:22206623 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC27A4 mRNA CTD PMID:33387578 hydroquinone O-beta-D-glucopyranoside decreases expression ISO RGD:1316551 6480464 Arbutin results in decreased expression of SLC27A4 mRNA CTD PMID:17103032 ivermectin decreases expression ISO RGD:1316551 6480464 Ivermectin results in decreased expression of SLC27A4 protein CTD PMID:32959892 linalool increases expression ISO RGD:1316551 6480464 linalool results in increased expression of SLC27A4 mRNA, linalool results in increased expression of SLC27A4 protein CTD PMID:24752549 linalool multiple interactions ISO RGD:1316551 6480464 PPARA protein promotes the reaction [linalool results in increased expression of SLC27A4 protein] CTD PMID:24752549 linalool increases expression ISO RGD:1316552 6480464 linalool results in increased expression of SLC27A4 mRNA, linalool results in increased expression of SLC27A4 protein CTD PMID:24752549 linalool multiple interactions ISO RGD:1316552 6480464 PPARA gene mutant form inhibits the reaction [linalool results in increased expression of SLC27A4 mRNA], PPARA gene mutant form inhibits the reaction [linalool results in increased expression of SLC27A4 protein] CTD PMID:24752549 N-methyl-4-phenylpyridinium increases expression ISO RGD:1316551 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC27A4 mRNA CTD PMID:24767308 N-Nitrosopyrrolidine increases expression ISO RGD:1316551 6480464 N-Nitrosopyrrolidine results in increased expression of SLC27A4 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1316551 6480464 Nickel results in increased expression of SLC27A4 mRNA CTD PMID:25583101 nicotinic acid increases expression ISO RGD:1316551 6480464 Niacin results in increased expression of SLC27A4 mRNA CTD PMID:24767308 oleic acid multiple interactions ISO RGD:1316552 6480464 PPARA protein promotes the reaction [Oleic Acid results in increased expression of SLC27A4 mRNA] CTD PMID:18489776 paracetamol multiple interactions ISO RGD:1316552 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC27A4 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC27A4 mRNA] CTD PMID:17585979 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC27A4 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1316551 6480464 Acetaminophen results in increased expression of SLC27A4 mRNA CTD PMID:29067470 paracetamol decreases expression ISO RGD:1316551 6480464 Acetaminophen results in decreased expression of SLC27A4 mRNA CTD PMID:21420995 PCB138 affects expression ISO RGD:1316551 6480464 2 more ... CTD PMID:21703328 perfluorohexanesulfonic acid increases expression ISO RGD:1316552 6480464 perfluorohexanesulfonic acid results in increased expression of SLC27A4 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1316552 6480464 PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of SLC27A4 mRNA] CTD PMID:20936131 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1316551 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC27A4 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1316552 6480464 perfluorooctane sulfonic acid results in increased expression of SLC27A4 mRNA CTD PMID:20936131 , PMID:21705711 perfluorooctanoic acid increases expression ISO RGD:1316552 6480464 perfluorooctanoic acid results in increased expression of SLC27A4 mRNA CTD PMID:18467677 , PMID:30657992 perfluorooctanoic acid multiple interactions ISO RGD:1316552 6480464 Dietary Fats more ... CTD PMID:18467677 , PMID:23626681 pirinixic acid multiple interactions ISO RGD:1316552 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC27A4 mRNA more ... CTD PMID:18467677 more ... pirinixic acid increases expression ISO RGD:1316552 6480464 pirinixic acid results in increased expression of SLC27A4 mRNA CTD PMID:15375163 more ... potassium chromate decreases expression ISO RGD:1316551 6480464 potassium chromate(VI) results in decreased expression of SLC27A4 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1316551 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC27A4 mRNA CTD PMID:22079256 rac-lactic acid decreases expression ISO RGD:1316551 6480464 Lactic Acid results in decreased expression of SLC27A4 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:1316552 6480464 resveratrol results in increased expression of SLC27A4 protein CTD PMID:25505154 SB 431542 multiple interactions ISO RGD:1316551 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A4 mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1316551 6480464 sodium arsenite results in increased expression of SLC27A4 mRNA CTD PMID:34032870 sodium fluoride decreases expression ISO RGD:1316552 6480464 Sodium Fluoride results in decreased expression of SLC27A4 protein CTD PMID:28918527 sulforaphane multiple interactions ISO RGD:1316552 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC27A4 mRNA CTD PMID:30529165 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of SLC27A4 mRNA CTD PMID:24136188 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC27A4 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:1316552 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC27A4 mRNA CTD PMID:29950665 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC27A4 mRNA CTD PMID:33387578 tungsten decreases expression ISO RGD:1316552 6480464 Tungsten results in decreased expression of SLC27A4 mRNA CTD PMID:30912803 valproic acid increases expression ISO RGD:1316552 6480464 Valproic Acid results in increased expression of SLC27A4 mRNA CTD PMID:24489787 valproic acid affects expression ISO RGD:1316551 6480464 Valproic Acid affects the expression of SLC27A4 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1316551 6480464 Valproic Acid results in increased expression of SLC27A4 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1316551 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC27A4 mRNA CTD PMID:27188386